Shares of Sapiens International Co. (NASDAQ:SPNS) have received a consensus rating of “Buy” from the eight ratings firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $35.00.
A number of equities analysts have commented on the company. The Goldman Sachs Group lowered Sapiens International from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $34.00 to $27.00 in a research note on Thursday, June 3rd. Zacks Investment Research downgraded Sapiens International from a “buy” rating to a “hold” rating in a research note on Tuesday, May 4th.
A number of institutional investors have recently added to or reduced their stakes in SPNS. BlackRock Inc. raised its stake in Sapiens International by 1.1% during the first quarter. BlackRock Inc. now owns 1,330,447 shares of the technology company’s stock worth $42,296,000 after acquiring an additional 15,124 shares in the last quarter. Phoenix Holdings Ltd. boosted its stake in shares of Sapiens International by 156.1% in the 1st quarter. Phoenix Holdings Ltd. now owns 1,310,938 shares of the technology company’s stock valued at $41,675,000 after purchasing an additional 799,047 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its holdings in shares of Sapiens International by 2.4% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 622,938 shares of the technology company’s stock valued at $23,522,000 after purchasing an additional 14,789 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Sapiens International by 13.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 392,437 shares of the technology company’s stock worth $12,486,000 after purchasing an additional 46,004 shares in the last quarter. Finally, Royal Bank of Canada lifted its stake in Sapiens International by 1.7% in the 1st quarter. Royal Bank of Canada now owns 376,953 shares of the technology company’s stock valued at $11,983,000 after purchasing an additional 6,364 shares during the last quarter. Hedge funds and other institutional investors own 25.87% of the company’s stock.
Sapiens International (NASDAQ:SPNS) last posted its quarterly earnings data on Tuesday, May 4th. The technology company reported $0.27 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.27. Sapiens International had a net margin of 9.15% and a return on equity of 16.69%. The firm had revenue of $110.22 million during the quarter, compared to the consensus estimate of $109.93 million. During the same quarter in the previous year, the firm posted $0.20 EPS. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. Equities analysts anticipate that Sapiens International will post 1.04 EPS for the current year.
The firm also recently disclosed a — dividend, which was paid on Tuesday, May 11th. Investors of record on Tuesday, April 27th were given a dividend of $0.37 per share. The ex-dividend date was Monday, April 26th. This represents a dividend yield of 1.1%. Sapiens International’s dividend payout ratio is currently 29.79%.
About Sapiens International
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities.
Recommended Story: Resistance Level
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.